Introduction
============

Both the incidence^[@b1]--[@b11]^ of and in‐hospital mortality^[@b1]--[@b7],[@b12]--[@b15]^ from acute myocardial infarctions (AMI), particularly ST‐elevation AMI (STEMI), has declined in the United States during the last decade. Regardless of such improvements in disease management, AMI remains the leading cause of death in the United States.^[@b12]^ Several studies have examined the time trend in the clinical outcome (eg, in‐hospital mortality rate, 30‐day mortality rate) and costs of care for AMI both at regional and national levels.^[@b1]--[@b9],[@b13]--[@b18]^ But to the best of our knowledge, no study has evaluated whether time trend differs by the type of AMI and the intervention the patients received.

In this context, we examined whether the time trends for in‐hospital mortality and hospital costs for AMI hospitalizations differ by the type of AMI and the intervention performed during hospitalization from 2001 to 2011 using nationally representative data of AMI hospitalizations in the United States.

Methods
=======

Design and Settings
-------------------

We conducted a serial cross‐sectional analysis of hospitalizations from 2001 through 2011, using the Healthcare Cost and Utilization Project (HCUP) Nationwide Impatient Sample (NIS).^[@b19]^ The NIS is a stratified, single‐stage cluster sample, which represents one of the largest all‐payer inpatient care data in the United States. NIS samples approximately 8 million hospital discharges per year from hospitals in those states participating in HCUP (eg, NIS 2011---1045 hospitals from 46 states). NIS offers a weight variable and study design variables that enable production of national estimates and their variances of all hospitalizations in the United States during the year. The institutional review boards of Massachusetts General Hospital (Boston, MA) and the University of Tokyo (Tokyo, Japan) approved this study.

Study Participants
------------------

All hospitalizations between 2001 and 2011 for patients aged 30 years or older with principal diagnosis of AMI were included in this study. We excluded patients with the hospital length of stay of zero (LOS) because they may have resulted from coding errors, our interest was in ordinary AMI patients who stayed longer than 1 day and the characteristics of the AMI patients with zero LOS (eg, those who were transferred to other institutions or who died within 24 hours of admission) are likely to be different from them, and technically we could not calculate the geometric mean of LOS when the data include zeros. We identified an AMI hospitalization using the *International Classification of Diseases*---*Ninth Revision, Clinical Modification* (*ICD‐9‐CM*) primary discharge diagnosis code for AMI (*ICD‐9‐CM* codes 410.x0 and 410.x1). We excluded *ICD‐9‐CM* codes 410.x2 which represents an AMI episode of care following the initial episode (eg, hospital transfers). The primary unit of analysis was a patient hospitalization, counted at discharge. We further classified the hospitalizations into 2 groups by the type of AMI: STEMI and NSTEMI. STEMI was identified by using codes for AMIs of the anterolateral wall (*ICD‐9‐CM* codes of 410.00 and 410.01), other anterior wall (410.10 and 410.11), inferolateral wall (410.20 and 410.21), inferoposterior wall (410.30 and 410.31), other inferior wall (410.40 and 410.41), other lateral wall (410.50 and 410.51), true posterior wall (410.60 and 410.61), or other specified sites (410.80 and 410.81). NSTEMI was identified using codes for subendocardial infarction (410.70 and 410.71) or AMI of unspecified site (410.90 and 410.91). Because each discharge has a unique primary discharge diagnosis code, all included in our sample were classified as either STEMI or NSTEMI. We also collected information about the intervention received (percutaneous coronary intervention \[PCI\] and coronary artery bypass grafting \[CABG\]) using the ICD‐9‐CM procedure code. We considered discharges as having undergone PCI during hospitalization when they had procedure codes of percutaneous transluminal coronary angioplasty or coronary atherectomy (00.66, 36.01, 36.02, 36.05), insertion of non‐drug‐eluting coronary artery stent(s) (36.06), or insertion of drug‐eluting coronary artery stent(s) (36.07). We considered discharges as having undergone CABG during hospitalization when they had procedure codes of bypass anastomosis for heart revascularization (36.1x). Patients "without intervention" were defined as those having neither of PCI nor CABG during hospitalizations.

Outcome Measures
----------------

Primary outcomes of this study were the all‐cause in‐hospital mortality and costs per hospitalization for AMI. Secondary outcome measures included total costs per hospitalization and hospital length of stay (LOS). Although hospital charges per discharge (physician fees not included) were available in NIS, actual cost data were not available in NIS. Therefore, we used hospital‐specific cost‐to‐charge ratios (CCRs) provided by HCUP and converted charges into costs.^[@b20]^ When hospital‐specific CCRs were not available, we used group average CCRs instead. The hospital accounting reports collected by the Centers for Medicare and Medicaid Services were used to obtain CCR information. The cases without any CCR information were excluded from the analyses (missing data in \<10% of eligible cases), and the data were appropriately reweighted to calculate the national estimates of the costs, as suggested by the HCUP.^[@b20]^ To facilitate direct comparisons between years for hospital costs, we converted all hospital costs to 2011 US dollars using the Consumer Price Index (CPI).^[@b21]^

Other Variables
---------------

We collected information about both patient‐ and hospital‐level characteristics that are associated with the mortality and costs of care, and used them as adjustment variables in our regression models. The collected patient characteristics include age at admission, gender, primary health insurance type, hospitalization source, and comorbidities. We did not include race/ethnicity in our analyses because the data were missing for quite a large portion of units (26% missing in 2001), and the race/ethnicity information in the HCUP data was considered to be missing not at random. Age at admission was categorized by 10 years. Health insurance type was categorized as Medicaid, Medicare, private, or others including the uninsured. Hospitalization source was dichotomized into elective hospitalization or not. Comorbidities were assessed using *Clinical Classifications Software* (CCS) developed by AHRQ based on the methods by Elixhauser et al,^[@b22]^ and all comorbidities included in the Elixhauser Comorbidity Index were adjusted except congestive heart failure. The hospital factors include bed size, hospital ownership, hospital region, and a category made of urban/rural distinction and teaching status. With regard to hospital characteristics, bed size was categorized as small, medium, or large based on the number of hospital beds using cut‐off points specific to the hospital\'s region, location, and teaching status. Ownership of the hospital was grouped as government nonfederal, private non‐profit, and private investor‐own. Hospital regions consist of Northeast, Midwest, South, and West. Hospital location (urban or rural) and teaching status were jointly categorized as rural, urban non‐teaching, and urban teaching.

Statistical Analyses
--------------------

All analyses used SAS‐callable SUDAAN, version 11.0 (Research Triangle Institute, Research Triangle Park, NC) to obtain appropriate variance estimations that accounted for the complex survey sampling design. We calculated AMI hospitalization incidence rates (the number of estimated hospitalizations per 1000 populations) using the population estimates.^[@b23]^ Poisson regression was used to calculate *P* values for the trend (*P*~trend~) for the incidence rates. The proportion of STEMI among all AMI hospitalizations was calculated, and the time trend was assessed using the logistic regression models using the year indicator as continuous variable. Weighted estimates of patient and hospital characteristics for each year were described for all AMI discharges, and also separately for STEMI and NSTEMI cases. We also calculated the proportion of cases with PCI and CABG for STEMI and NSTEMI hospitalizations. Logistic regression analyses with year variable used as continuous were used to assess the time trends of the proportions of PCI and CABG use.

Next, we examined the trends of in‐hospital mortality stratified by the type of AMI and the intervention received. We classified AMI hospitalizations into 6 groups: (1) STEMI with PCI, (2) STEMI with CABG, (3) STEMI without intervention, (4) NSTEMI with PCI, (5) NSTEMI with CABG, and (6) NSTEMI without intervention. We evaluated both unadjusted and adjusted time trend by fitting logistic regression models with the year indicator used as a continuous variable. The patient‐ and hospital‐level characteristics adjusted in the evaluation of the adjusted association are listed in Other Variables. In order to account for the clustering of the hospitalizations at hospital‐level, we used generalized estimating equations (GEE) with logistic link function. An exchangeable working correlation structure was selected, as this correlation matrix is most widely used for health data and any permutation is valid.^[@b24]^

We also examined the temporal trends of hospital costs per hospitalization. Because hospital costs per hospitalization were not normally distributed, we log‐transformed the costs per hospitalization, took the average of the logarithmic values, and then back‐transformed the average, calculating a geometric mean. We then constructed linear regression models with log‐transformed costs as the outcome variable to estimate the percent changes of hospital costs per hospitalization from 2001. We used similar methods for the analysis of the temporal trends of LOS.

We also estimated aggregate national hospital costs on AMI hospitalizations in the United States adjusted for CPI by means of aggregating all the CPI‐adjusted costs of all AMI hospitalizations for each year.

Results
=======

From 2001 through 2011, we identified a total of 1 456 154 patient discharges of AMI in the United States, corresponding to a weighted estimate of 7 135 592 discharges. Characteristics of the hospitalized patients with AMI over the 11‐year period are presented in [Table 1](#tbl01){ref-type="table"}. There was missing information for each demographic variable as follows: 158 (0.01%) missing gender, 2608 (0.2%) missing payer, 139 082 (9.6%) missing type of admission, 5969 (0.4%) missing bed size and location/teaching status, and 17 799 (1.2%) missing ownership of hospital. There was no missing value with regard to age and hospital region.

###### 

Patient and Hospital Characteristics of US Adults 30 Years or Older Hospitalized for Acute Myocardial Infarction, 2000--2011

                                                                2001              2002              2003              2004              2005             2006             2007             2008             2009             2010             2011             *P* ~trend~ [\*](#tf1-1){ref-type="table-fn"}
  ------------------------------------------------------------- ----------------- ----------------- ----------------- ----------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- -----------------------------------------------
  Unweighted sample, n                                          147 587           151 171           150 131           136 881           129 655          132 811          121 067          126 316          121 060          116 631          122 844          
  Weighted sample, n                                            738 365           730 786           718 838           664 507           635 145          647 880          599 749          619 657          609 417          582 861          588 387          
  Incidence rates of AMI hospitalizations per 1000 population   4.5               4.4               4.2               3.9               3.7              3.7              3.4              3.5              3.4              3.2              3.2              \<0.001
  STEMI among AMI hospitalization, unweighted %                 59 363 (40.2%)    59 251 (39.1%)    56 116 (37.3%)    47 232 (34.6%)    43 056 (33.1%)   44 546 (33.4%)   37 631 (31.0%)   37 670 (29.8%)   34 186 (28.2%)   32 626 (28.0%)   33 114 (26.9%)   \<0.001
  Patient variables                                                                                                                                                                                                                                            
  Age, mean, year (SD)                                          68.4 (14.0)       68.2 (14.2)       68.1 (14.3)       68.2 (14.3)       68.2 (14.5)      67.6 (14.4)      67.7 (14.5)      67.9 (14.5)      67.5 (14.4)      67.5 (14.4)      67.7 (14.3)      0.64
  Female gender, unweighted n (weighted %)                      60 665 (41.1%)    61 980 (41.1%)    61 425 (41.0%)    55 922 (40.8%)    52 840 (40.8%)   52 810 (39.9%)   48 852 (40.4%)   50 977 (40.4%)   47 758 (39.5%)   46 154 (39.6%)   48 373 (39.4%)   \<0.001
  Health insurance, unweighted n (weighted %)                                                                                                                                                                                                                  
  Medicare                                                      87 078 (59.1%)    89 234 (59.3%)    89 242 (59.7%)    80 398 (58.8%)    76 738 (59.3%)   75 492 (57.1%)   68 328 (56.6%)   71 087 (56.4%)   67 502 (56.1%)   65 162 (55.9%)   70 433 (57.6%)   \<0.001
  Medicaid                                                      6630 (4.5%)       6707 (4.5%)       7492 (5.0%)       6601 (4.8%)       6664 (5.1%)      6515 (4.9%)      5980 (5.0%)      6861 (5.4%)      7101 (5.9%)      7681 (6.6%)      7651 (6.3%)      \<0.001
  Private                                                       44 675 (30.4%)    45 138 (29.8%)    42 879 (28.5%)    39 067 (28.6%)    36 229 (28.0%)   39 038 (29.4%)   35 598 (29.5%)   36 515 (29.0%)   34 258 (28.2%)   32 317 (27.8%)   32 493 (26.5%)   \<0.001
  Others                                                        8809 (5.9%)       9848 (6.5%)       10 267 (6.8%)     10 707 (7.7%)     9885 (7.6%)      11 586 (8.6%)    10 927 (8.9%)    11 642 (9.2%)    11 936 (9.8%)    11 255 (9.7%)    11 900 (9.7%)    \<0.001
  Admission Type---Elective, unweighted n (weighted %)          12 790 (9.5%)     11 613 (8.4%)     13 201 (9.7%)     11 244 (8.9%)     8875 (7.8%)      10 707 (8.7%)    9023 (8.2%)      8053 (7.0%)      6219 (5.6%)      7686 (7.3%)      6960 (6.3%)      \<0.001
  Hospital variables                                                                                                                                                                                                                                           
  Bed size, unweighted n (weighted %)                                                                                                                                                                                                                          
  Small                                                         13 769 (9.2%)     15 543 (9.6%)     15 198 (9.6%)     14 830 (9.9%)     9474 (7.2%)      15 606 (11.4%)   12 631 (9.1%)    12 870 (10.0%)   10 273 (8.5%)    12 293 (9.7%)    11 638 (9.4%)    0.97
  Medium                                                        35 165 (23.4%)    35 957 (24.0%)    37 116 (24.2%)    33 046 (23.1%)    31 180 (24.0%)   32 499 (24.5%)   29 494 (24.5%)   28 989 (22.5%)   25 205 (21.4%)   24 237 (20.9%)   27 535 (23.6%)   0.42
  Large                                                         98 653 (67.5%)    99 671 (66.3%)    97 746 (66.2%)    89 005 (67.0%)    89 001 (68.9%)   84 339 (64.1%)   78 795 (66.3%)   84 337 (67.4%)   83 368 (70.1%)   78 554 (69.4%)   82 168 (67.0%)   0.49
  Ownership of hospital, unweighted n (weighted %)                                                                                                                                                                                                             
  Government, nonfederal                                        14 983 (10.0%)    13 994 (9.1%)     17 016 (11.1%)    15 187 (10.7%)    16 145 (11.5%)   13 103 (9.7%)    14 671 (11.7%)   15 328 (11.0%)   11 729 (9.7%)    12 602 (11.1%)   10 200 (8.1%)    0.86
  Private, non‐profit                                           112 612 (79.2%)   120 350 (80.6%)   111 414 (76.6%)   103 560 (77.6%)   94 693 (75.1%)   97 854 (76.1%)   88 826 (75.3%)   92 556 (74.2%)   91 908 (77.1%)   86 443 (74.8%)   93 852 (77.5%)   0.11
  Private, investor‐own                                         17 177 (10.8%)    16 168 (10.3%)    19 310 (12.2%)    16 285 (11.7%)    18 027 (13.4%)   19 988 (14.2%)   15 525 (13.0%)   18 312 (14.8%)   15 209 (13.2%)   16 039 (14.1%)   17 289 (14.4%)   0.03
  Region, unweighted n (weighted %)                                                                                                                                                                                                                            
  Northeast                                                     31 587 (21.7%)    31 498 (22.6%)    31 393 (21.3%)    28 796 (20.8%)    27 396 (21.6%)   24 985 (20.3%)   22 081 (20.3%)   22 434 (18.0%)   22 761 (19.7%)   22 785 (19.7%)   22 394 (18.7%)   0.18
  Midwest                                                       30 285 (22.2%)    32 016 (21.5%)    33 790 (23.3%)    29 893 (23.4%)    28 130 (22.0%)   29 225 (23.0%)   27 991 (24.0%)   30 148 (24.6%)   27 346 (22.5%)   29 014 (25.1%)   27 789 (22.2%)   0.54
  South                                                         62 269 (40.8%)    61 255 (39.2%)    61 507 (39.2%)    54 938 (38.6%)    52 253 (39.9%)   56 728 (40.8%)   48 466 (38.8%)   52 418 (40.5%)   50 079 (41.3%)   43 147 (37.5%)   49 851 (40.2%)   0.99
  West                                                          23 446 (15.3%)    26 402 (16.6%)    23 441 (16.1%)    23 254 (17.3%)    21 876 (16.5%)   21 873 (15.9%)   22 529 (16.9%)   21 316 (16.8%)   20 874 (16.5%)   21 685 (17.7%)   22 810 (18.9%)   0.28
  Location/teaching status, unweighted n (weighted %)                                                                                                                                                                                                          
  Rural                                                         20 775 (14.4%)    20 160 (13.7%)    18 472 (13.6%)    14 512 (11.2%)    13 399 (10.7%)   11 983 (9.5%)    13 517 (10.8%)   14 062 (11.0%)   12 063 (9.8%)    14 249 (11.3%)   10 518 (9.2%)    0.003
  Urban nonteaching                                             64 892 (41.9%)    65 739 (42.5%)    66 250 (42.7%)    60 638 (43.9%)    61 874 (46.8%)   57 116 (41.5%)   51 857 (42.3%)   55 873 (44.8%)   50 533 (43.6%)   50 072 (43.5%)   53 060 (42.8%)   0.76
  Urban teaching                                                61 920 (43.7%)    65 272 (43.8%)    65 338 (43.7%)    61 731 (44.8%)    54 382 (42.5%)   63 345 (49.0%)   55 546 (46.9%)   56 261 (44.2%)   56 250 (46.6%)   50 763 (45.3%)   57 763 (47.9%)   0.26

AMI indicates acute myocardial infarction; SD, standard deviation; STEMI, ST‐elevation acute myocardial infarction; US, United States.

*P*~trend~ was calculated by Poisson regression for incident rate of hospitalization, and logistic regression for categorical outcomes.

Incidence
---------

The overall rate of AMI hospitalizations declined significantly during the study period (4.5 per 1000 populations in 2001 to 3.2 per 1000 populations in 2011; 29% decrease; *P*~trend~\<0.001, [Table 1](#tbl01){ref-type="table"}). The proportion of STEMI among AMI hospitalizations also decreased (40.2% in 2001 to 26.9% in 2011; 33% decrease; *P*~trend~\<0.001). In more recent years, patients hospitalized for AMI were more likely to be male, less likely to be admitted as elective hospitalization, more likely to be admitted to private investor‐owned hospitals, and less likely to be admitted to rural hospitals.

Use of PCI and CABG for AMI
---------------------------

The weighted proportion of PCI and CABG use was calculated and shown in [Table 2](#tbl02){ref-type="table"}. During the study period, the use of PCI increased significantly for both the STEMI (75% increase; *P*~trend~\<0.001) and NSTEMI patients (54% increase; *P*~trend~\<0.001). By contrast, the CABG use decreased for both STEMI (39% decrease; P~trend~\<0.001) and NSTEMI (14% decrease; *P*~trend~=0.005). Both the proportion of PCI use and the rate of increase in PCI use among STEMI hospitalizations were greater compared with those among NSTEMI hospitalizations.

###### 

Weighted Proportion of STEMI/NSTEMI Hospitalizations by Type of Intervention (Only PCI, CABG, and Without Intervention), 2001--2011

                                   2001    2002    2003    2004    2005    2006    2007    2008    2009    2010    2011    *P* ~trend~ [\*](#tf2-1){ref-type="table-fn"}
  ---------------------- --------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -----------------------------------------------
  STEMI                                                                                                                    
  Only PCI               285 799   43.7%   46.7%   50.3%   53.7%   57.9%   62.3%   65.4%   69.7%   73.0%   75.3%   76.6%   \<0.001
  CABG                   46 303    10.9%   11.1%   10.6%   10.3%   9.7%    9.9%    9.2%    8.2%    8.2%    6.7%    6.7%    \<0.001
  Without intervention   152 689   45.4%   42.2%   39.2%   36.0%   32.4%   27.8%   25.4%   22.1%   18.8%   18.0%   16.8%   \<0.001
  NSTEMI                                                                                                                   
  Only PCI               278 784   22.0%   22.6%   24.6%   27.2%   28.9%   31.3%   29.8%   30.8%   33.0%   32.6%   33.9%   \<0.001
  CABG                   95 007    10.5%   10.7%   10.2%   9.8%    9.3%    10.1%   9.4%    9.3%    9.9%    9.3%    9.0%    0.005
  Without intervention   597 572   67.6%   66.7%   65.2%   63.0%   61.9%   58.6%   60.9%   59.9%   57.2%   58.1%   57.1%   \<0.001

CABG indicates coronary artery bypass grafting; CI, confidence interval; NSTEMI, non‐ST‐elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST‐elevation myocardial infarction.

*P*~trend~ was calculated using logistic regression models with a continuous year variable as the independent variable.

In‐Hospital Mortality
---------------------

We observed differential time trends of unadjusted in‐hospital mortality by the type of AMI and the type of intervention ([Table 3](#tbl03){ref-type="table"}). For STEMI, in‐hospital mortality increased among those who did not receive intervention (20% increase, *P*~trend~\<0.001). On the other hand, the mortality did not change significantly among those who received PCI (3.5% increase, *P*~trend~=0.12) or CABG (1.6% decrease, *P*~trend~=0.14). Among NSTEMI cases, in‐hospital mortality decreased significantly, especially among those who did not receive intervention (29% decrease; *P*~trend~\<0.001) and those who underwent CABG (41% decrease; *P*~trend~\<0.001). We did not find a systematic pattern as to the in‐hospital mortality among NSTEMI patients who received PCI (16% decrease, *P*~trend~=0.29).

###### 

Unadjusted Trend of in‐Hospital Mortality and Geometric Means of Hospital Costs, and Hospital Length of Stay, by STEMI/NSTEMI and PCI/CABG Use

                                    2001     2002     2003     2004     2005     2006     2007     2008     2009     2010     2011     *P* ~trend~ [\*](#tf3-1){ref-type="table-fn"}
  --------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -----------------------------------------------
  In‐hospital mortality, %                                                                                                             
  STEMI with only PCI               3.40     3.33     3.12     3.05     3.21     3.14     3.32     3.48     3.41     3.35     3.52     0.12
  STEMI with CABG                   5.79     5.23     5.41     5.43     6.23     5.13     4.92     5.04     5.15     4.53     5.70     0.14
  STEMI without intervention        12.43    12.96    13.01    12.92    13.18    12.94    14.52    14.57    15.21    14.51    14.91    \<0.001
  NSTEMI with only PCI              1.73     1.69     1.47     1.59     1.48     1.52     1.58     1.64     1.71     1.52     1.45     0.29
  NSTEMI with CABG                  4.97     4.77     4.66     4.31     4.30     3.72     3.96     3.59     3.60     2.97     2.91     \<0.001
  NSTEMI without intervention       8.87     8.79     8.64     8.49     8.05     7.57     6.88     6.96     6.47     6.33     6.26     \<0.001
  Hospital costs, dollars in 2011                                                                                                      
  STEMI with only PCI               17 182   18 230   18 820   20 605   20 661   20 266   19 729   19 917   19 661   19 782   19 614   \<0.001
  STEMI with CABG                   36 923   38 635   40 097   41 992   43 968   42 777   44 962   44 919   45 282   45 647   45 935   \<0.001
  STEMI without intervention        8746     9207     9196     9368     9077     9242     9660     9917     9969     10,183   10,246   \<0.001
  NSTEMI with only PCI              15 636   16 519   17 776   19 983   19 874   19 342   18 532   18 954   18 607   18 766   18 733   \<0.001
  NSTEMI with CABG                  35 700   36 456   39 278   41 338   42 319   40 959   42 746   41 885   42 428   42 652   43 182   \<0.001
  NSTEMI without intervention       7837     8220     8553     8859     8701     8866     8698     8771     8627     8617     8474     \<0.001
  Hospital length of stay, days                                                                                                        
  STEMI with only PCI               3.57     3.56     3.50     3.46     3.37     3.29     3.27     3.22     3.19     3.14     3.07     \<0.001
  STEMI with CABG                   9.42     9.38     9.39     9.33     9.52     9.34     9.57     9.62     9.55     9.31     9.31     0.69
  STEMI without intervention        3.47     3.51     3.44     3.43     3.39     3.37     3.43     3.48     3.48     3.40     3.32     0.09
  NSTEMI with only PCI              3.14     3.12     3.21     3.17     3.04     2.94     2.85     2.88     2.91     2.90     2.86     \<0.001
  NSTEMI with CABG                  10.03    9.86     10.09    10.44    10.45    10.15    10.46    10.31    10.25    9.95     10.31    0.22
  NSTEMI without intervention       3.84     3.81     3.85     3.78     3.75     3.68     3.55     3.60     3.48     3.39     3.27     \<0.001

CABG indicates coronary artery bypass grafting; NSTEMI, non‐ST‐elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST‐elevation myocardial infarction.

*P*~trend~ was calculated using logistic regression models for mortality and linear regression models for continuous outcome variables.

After controlling for both patient‐ and hospital‐level characteristics, we found that in‐hospital mortality improved dramatically among NSTEMI patients regardless of the type of treatments they received. The patient outcomes improved for those patients who received PCI (OR 0.68, 95% CI 0.56 to 0.83), CABG (OR 0.57, 95% CI 0.45 to 0.72), or without intervention (OR 0.61, 95% CI 0.57 to 0.65) ([Table 4](#tbl04){ref-type="table"} and [Figure 1](#fig01){ref-type="fig"}). As for STEMI patients, adjusted in‐hospital mortality improved for those who received PCI (OR 0.83, 95% CI 0.73 to 0.94), but no significant improvement was seen for those who underwent CABG (OR 0.92, 95% CI 0.72 to 1.19) or those without intervention (OR 0.98, 95% CI 0.88 to 1.09).

###### 

Adjusted[\*](#tf4-1){ref-type="table-fn"} Trend of in‐Hospital Mortality by STEMI/NSTEMI and PCI/CABG Use

                                Unweighted n (%)[\*](#tf4-2){ref-type="table-fn"}   2001   2002                  2003                  2004                  2005                  2006                  2007                  2008                  2009                  2010                  2011
  ----------------------------- --------------------------------------------------- ------ --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ---------------------
  STEMI with only PCI           253,624 (88.7%)                                     Ref.   0.95 (0.84 to 1.06)   0.95 (0.84 to 1.07)   0.93 (0.82 to 1.06)   0.93 (0.83 to 1.06)   0.90 (0.80 to 1.01)   0.92 (0.82 to 1.04)   0.91 (0.81 to 1.02)   0.88 (0.77 to 0.99)   0.86 (0.76 to 0.98)   0.83 (0.73 to 0.94)
  STEMI with CABG               40,322 (87.1%)                                      Ref.   0.98 (0.80 to 1.20)   1.06 (0.88 to 1.29)   0.99 (0.81 to 1.20)   1.11 (0.89 to 1.39)   0.87 (0.70 to 1.09)   0.85 (0.68 to 1.06)   0.82 (0.65 to 1.04)   0.92 (0.73 to 1.16)   0.80 (0.62 to 1.04)   0.92 (0.72 to 1.19)
  STEMI without intervention    128,741 (84.3%)                                     Ref.   0.94 (0.88 to 1.01)   1.00 (0.93 to 1.07)   0.96 (0.89 to 1.03)   0.91 (0.84 to 0.98)   0.86 (0.80 to 0.94)   0.94 (0.86 to 1.03)   0.99 (0.90 to 1.08)   0.99 (0.89 to 1.09)   0.93 (0.84 to 1.03)   0.98 (0.88 to 1.09)
  NSTEMI with only PCI          248,827 (89.3%)                                     Ref.   1.10 (0.92 to 1.30)   0.94 (0.79 to 1.13)   0.96 (0.80 to 1.15)   0.85 (0.71 to 1.02)   0.89 (0.76 to 1.06)   0.91 (0.76 to 1.09)   0.90 (0.75 to 1.08)   0.89 (0.74 to 1.08)   0.76 (0.63 to 0.91)   0.68 (0.56 to 0.83)
  NSTEMI with CABG              83,905 (88.3%)                                      Ref.   1.08 (0.89 to 1.31)   1.09 (0.90 to 1.32)   0.96 (0.79 to 1.16)   0.95 (0.78 to 1.16)   0.76 (0.62 to 0.94)   0.82 (0.67 to 0.99)   0.76 (0.62 to 0.94)   0.79 (0.66 to 0.95)   0.66 (0.53 to 0.82)   0.57 (0.45 to 0.72)
  NSTEMI without intervention   522,220 (87.4%)                                     Ref.   0.91 (0.86 to 0.96)   0.93 (0.88 to 0.98)   0.88 (0.83 to 0.93)   0.82 (0.77 to 0.87)   0.74 (0.70 to 0.79)   0.67 (0.63 to 0.71)   0.67 (0.63 to 0.71)   0.63 (0.59 to 0.68)   0.63 (0.59 to 0.67)   0.61 (0.57 to 0.65)

CABG, coronary artery bypass grafting; CI, confidential interval; NSTEMI, non‐ST‐elevation myocardial infarction; PCI, percutaneous coronary intervention; Ref, reference; STEMI, ST‐elevation myocardial infarction.

Adjusted for patient‐level characteristics (ie, age category, gender, primary payer, admission source, and all comorbidity variables from Elixhauser Comorbidity Index but the variable for congestive heart failure) and hospital‐level characteristics (hospital bed size, ownership of the hospital, hospital regions, and the variable for hospital location and teaching‐status) in multiple regressions stratified by STEMI/NSTEMI and PCI/CABG use.

Number of observations in each regression and the proportion in the subgroup was presented.

![Temporal trends of in‐hospital mortality for acute myocardial infarction hospitalizations in the United States by ST‐elevation/non‐ST‐elevation and percutaneous coronary intervention/cardiac bypass graft stenting use. Year 2001 was used as the reference. CABG indicates coronary artery bypass grafting; PCI, percutaneous coronary intervention; STEMI, non‐ST‐elevation myocardial infarction.](jah3-4-e001445-g1){#fig01}

Hospital Costs per Hospitalization
----------------------------------

The trends in hospital costs were assessed using unadjusted ([Table 3](#tbl03){ref-type="table"}) and adjusted analyses ([Table 5](#tbl05){ref-type="table"} and [Figure 2](#fig02){ref-type="fig"}). From 2001 to 2011, the hospital costs increased significantly across the subgroups. In the adjusted analyses, the increases in geometric means in 2011 compared with those in 2001 were larger among those with PCI or CABG than among those without intervention. The largest increase was found among STEMI hospitalizations that underwent CABG (20.7% increase; 95% CI, 14.6% to 27.1%).

###### 

Adjusted[\*](#tf5-1){ref-type="table-fn"} Trend of Geometric Means of Hospital Costs by STEMI/NSTEMI and PCI/CABG Use

                                n (%)[\*](#tf5-2){ref-type="table-fn"}   2001   2002                   2003                    2004                     2005                     2006                     2007                     2008                     2009                     2010                     2011
  ----------------------------- ---------------------------------------- ------ ---------------------- ----------------------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------
  STEMI with only PCI           234,627 (82.1%)                          Ref.   +7.0% (2.6 to 11.6%)   +10.9% (5.2 to 17.0%)   +18.6% (12.4 to 25.2%)   +19.8% (14.2 to 25.6%)   +17.5% (12.3 to 23.0%)   +12.3% (7.1 to 17.7%)    +14.4% (9.2 to 19.9%)    +11.2% (6.4 to 16.3%)    +7.3% (1.5 to 13.5%)     +10.0% (4.9 to 15.3%)
  STEMI with CABG               36,682 (79.2%)                           Ref.   +7.6% (3.4 to 12.0%)   +14.4% (8.6 to 20.5%)   +16.7% (11.0 to 22.6%)   +21.4% (15.7 to 27.5%)   +20.4% (14.5 to 26.6%)   +23.7% (18.0 to 29.8%)   +25.3% (19.2 to 31.7%)   +22.1% (16.1 to 28.3%)   +20.0% (12.4 to 28.2%)   +20.7% (14.6 to 27.1%)
  STEMI without intervention    117,756 (77.1%)                          Ref.   +4.8% (1.9 to 7.8%)    +4.1% (0.9 to 7.3%)     +3.7% (0.1 to 7.5%)      +1.9% (−1.4 to 5.2%)     +1.7% (−1.7 to 5.3%)     +2.3% (−1.6 to 6.4%)     +5.0% (1.1 to 9.0%)      +0.9% (−3.5 to 5.6%)     −1.8% (−6.4 to 3.0%)     +1.9% (−2.7 to 6.7%)
  NSTEMI with only PCI          231,900 (83.2%)                          Ref.   +7.3% (2.2 to 12.6%)   +16.2% (9.2 to 23.6%)   +25.0% (17.0 to 33.7%)   +24.2% (17.7 to 31.2%)   +23.6% (17.4 to 30.0%)   +15.7% (10.0 to 21.7%)   +18.3% (12.8 to 24.1%)   +15.0% (9.3 to 20.9%)    +9.3% (2.1 to 17.0%)     +10.5% (5.0 to 16.3%)
  NSTEMI with CABG              77,578 (81.7%)                           Ref.   +7.4% (3.6 to 11.4%)   +14.6% (9.1 to 20.3%)   +16.3% (11.3 to 21.6%)   +19.3% (14.5 to 24.2%)   +18.7% (13.1 to 24.6%)   +20.6% (15.5 to 25.8%)   +23.0% (18.1 to 28.1%)   +20.1% (15.3 to 25.1%)   +15.4% (9.1 to 22.0%)    +18.4% (13.3 to 23.7%)
  NSTEMI without intervention   484,894 (81.1%)                          Ref.   +5.4% (2.7 to 8.1%)    +9.8% (6.7 to 13.0%)    +9.6% (6.5 to 12.8%)     +9.3% (6.3 to 12.3%)     +7.6% (4.6 to 10.8%)     +4.5% (0.9 to 8.3%)      +6.4% (3.4 to 9.4%)      +1.8% (−1.4 to 5.1%)     −1.7% (−5.7 to 2.4%)     +0.5% (−2.6 to 3.7%)

CABG indicates coronary artery bypass grafting; CI, confidential interval; NSTEMI, non‐ST‐elevation myocardial infarction; PCI, percutaneous coronary intervention; Ref, reference; STEMI, ST‐elevation myocardial infarction.

Adjusted for patient‐level characteristics (ie, age category, gender, primary payer, admission source, and all comorbidity variables from Elixhauser Comorbidity Index but the variable for congestive heart failure) and hospital‐level characteristics (hospital bed size, ownership of the hospital, hospital regions, and the variable for hospital location and teaching‐status) in multiple regressions stratified by STEMI/NSTEMI and PCI/CABG use.

Number of observations in each regression and the proportion in the subgroup was presented. The numbers in cost analyses were fewer than others due to the missingness with regard to cost‐charge ratio; modified weight was used for cost analyses considering the missingness.

![Temporal trends of percent change of hospital costs for acute myocardial infarction hospitalizations in the United States by ST‐elevation/non‐ST‐elevation and percutaneous coronary intervention/cardiac bypass graft stenting use. Year 2001 was used as the reference. CABG indicates coronary artery bypass grafting; PCI, percutaneous coronary intervention; STEMI, non‐ST‐elevation myocardial infarction.](jah3-4-e001445-g2){#fig02}

Length of Stay
--------------

The LOS of AMI hospitalizations decreased, especially among those with PCI or those without intervention (eg, STEMI with PCI: 18.3% decrease, 95% CI, −20.5% to −16.1%). The decrease of LOS among those with CABG appeared smaller, and the trend was not statistically significant among NSTEMI hospitalization that underwent CABG (1.2% decrease, 95% CI, −4.5% to 2.3%) ([Table 6](#tbl06){ref-type="table"}).

###### 

Adjusted[\*](#tf6-1){ref-type="table-fn"} Trend of Geometric Means of Length of Stay by STEMI/NSTEMI and PCI/CABG Use

                                n (%)[\*](#tf6-2){ref-type="table-fn"}   2001   2002                   2003                    2004                    2005                    2006                      2007                       2008                       2009                       2010                       2011
  ----------------------------- ---------------------------------------- ------ ---------------------- ----------------------- ----------------------- ----------------------- ------------------------- -------------------------- -------------------------- -------------------------- -------------------------- --------------------------
  STEMI with only PCI           253,760 (88.8%)                          Ref.   −0.5% (−2.7 to 1.7%)   −1.4% (−3.8 to 1.0%)    −3.0% (−5.2 to −0.8%)   −6.3% (−8.9 to −3.7%)   −7.7% (−10.2 to −5.2%)    −8.7% (−11.1 to −6.3%)     −10.9% (−13.3 to −8.5%)    −12.7% (−14.9 to −10.5%)   −15.5% (−17.6 to −13.3%)   −18.3% (−20.5 to −16.1%)
  STEMI with CABG               40,410 (87.3%)                           Ref.   +2.4% (−0.5 to 5.5%)   +5.5% (2.3 to 8.8%)     +2.7% (−0.4 to 5.8%)    +2.3% (−1.3 to 6.0%)    +1.3% (−2.3 to 4.7%)      +3.7% (−0.1 to 7.7%)       +2.6% (−1.3 to 6.7%)       +1.3% (−2.7 to 5.5%)       −0.7% (−4.5 to 3.3%)       −4.1% (−8.2 to 0.2%)
  STEMI without intervention    128,937 (84.4%)                          Ref.   +0.5% (−1.6 to 2.7%)   −2.9% (−5.0 to −0.8%)   −4.4% (−6.6 to −2.2%)   −6.2% (−8.4 to −3.9%)   −9.9% (−12.2 to −7.4%)    −10.9% (−13.2 to −8.5%)    −10.7% (−13.2 to −8.1%)    −13.8% (−16.4 to −11.1%)   −16.7% (−19.2 to −14.0%)   −18.1% (−20.9 to −15.1%)
  NSTEMI with only PCI          248,942 (89.3%)                          Ref.   −0.7% (−3.7 to 2.5%)   0.7% (−2.3 to 3.8%)     −2.4% (−5.7 to 0.9%)    −6.0% (−9.2 to −2.7%)   −8.6% (−11.6 to −5.4%)    −11.0% (−14.0 to −7.9%)    −12.2% (−15.5 to −8.9%)    −14.5% (−17.2 to −11.6%)   −17.4% (−20.3 to −14.4%)   −20.6% (−23.3 to −17.8%)
  NSTEMI with CABG              84,087 (88.5%)                           Ref.   +2.6% (−0.5 to 5.7%)   +6.5% (3.3 to 9.7%)     6.6% (3.5 to 9.9%)      5.0% (1.8 to 8.4%)      +2.8% (−0.9 to 6.6%)      +5.6% (2.4 to 8.9%)        +4.8% (1.5 to 8.2%)        +3.7% (0.8 to 6.8%)        −0.1% (−3.5 to 3.4%)       −1.2% (−4.5 to 2.3%)
  NSTEMI without intervention   522,812 (87.5%)                          Ref.   −0.0% (−1.6 to 1.5%)   +0.0% (−1.6 to 1.5%)    −2.7% (−4.3 to −1.1%)   −5.5% (−7.2 to −3.8%)   −10.0% (−11.6 to −8.4%)   −12.9% (−14.4 to −11.4%)   −12.9% (−14.5 to −11.2%)   −16.7% (−18.2 to −15.1%)   −20.2% (−21.7 to −18.7%)   −22.1% (−23.5 to −20.6%)

CABG indicates coronary artery bypass grafting; CI, confidential interval; NSTEMI, non‐ST‐elevation myocardial infarction; PCI, percutaneous coronary intervention; Ref, reference; STEMI, ST‐elevation myocardial infarction.

Adjusted for patient‐level characteristics (ie, age category, gender, primary payer, admission source, and all comorbidity variables from Elixhauser Comorbidity Index but the variable for congestive heart failure) and hospital‐level characteristics (hospital bed size, ownership of the hospital, hospital regions, and the variable for hospital location and teaching‐status) in multiple regressions stratified by STEMI/NSTEMI and PCI/CABG use.

Number of observations in each regression and the proportion in the subgroup was presented.

Aggregate National Hospital Costs
---------------------------------

The aggregated national hospital costs in the United States are illustrated in [Table 7](#tbl07){ref-type="table"}. After adjusting for the inflation, hospital costs for AMI hospitalizations decreased nationally from \$12.4 billion in 2001 to \$11.3 billion in 2011 (9% decrease).

###### 

Aggregate National Hospital Costs on AMI Hospitalization, Adjusted for CPI, 2001--2011

                                                            2001         2002         2003         2004         2005         2006         2007         2008         2009         2010         2011
  --------------------------------------------------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
  Aggregate national hospital costs, billion dollars (SE)   12.4 (0.9)   13.1 (1.0)   13.2 (0.9)   13.1 (1.0)   12.7 (0.9)   13.1 (0.9)   11.6 (0.8)   12.1 (0.8)   11.9 (0.8)   11.3 (0.7)   11.3 (0.7)

AMI indicates acute myocardial infarction; CPI, consumer price index; SE, standard error.

Discussion
==========

By using a large, nationally representative database of US hospitalizations from 2001 to 2011, we found that differential time trends of in‐hospital mortality and hospital costs by the type of AMI and the type of intervention received. Most notably, adjusted in‐hospital mortality declined significantly for NSTEMI regardless of the type of intervention received. In contrast, among STEMI patients, the improvement in in‐hospital mortality was statistically significant only for those who underwent PCI, and no improvement was observed for those who received CABG or those without any intervention. Hospital costs increased significantly for those who received intervention; the rate of increase in hospital costs was most prominent among those patients who received CABG.

Previous studies have investigated the temporal trends of mortality and hospital costs for AMI patients. An analysis using the Kaiser Permanente Northern California dataset reported that 30‐day mortality of NSTEMI patients decreased, whereas the mortality of STEMI patients did not improve.^[@b4]^ Their sample was not a nationally representative sample of the US population, and the patients who underwent PCI and those who received CABG were not assessed separately. They also did not evaluate the cost data. Movahed et al examined the in‐hospital mortality for STEMI and NSTEMI patients using the HCUP NIS datasets,^[@b10]--[@b11],[@b15]--[@b16]^ but they did not stratify their analysis by the intervention received. Zhao and colleagues compared hospital costs by the intervention performed using a dataset of commercially insured individuals in the United States.^[@b25]^ Their data were again not a nationally representative sample, and they did not look into the time trends of hospital costs. To the best of our knowledge, this is the first study showing that the trends of in‐hospital mortality and hospital costs differ by type of AMI and intervention received during hospitalization.

There are multiple possible reasons for the observed decrease in mortality for NSTEMI without intervention and NSTEMI who underwent CABG. Consistent improvement in primary and secondary prevention of AMI---eg, appropriate prescription of aspirin, β‐blockers, and statins^[@b26]^---may affect mortality especially among these populations. Alternatively, patients with NSTEMI in more recent study periods may include patients diagnosed only by highly sensitive troponin but with less severe myocardial damage.^[@b4],[@b14]^ This could have led to the observed lower mortality in NSTEMI in recent years. Additionally, the indication of CABG for NSTEMI may have changed over time and become highly selective, thereby leading to lower mortality.

The increased hospital costs among AMI patients may come from the increasing trend in general medical spending.^[@b27]^ But the costs of devices and procedures supposedly increased faster than general medical spending considering the prominent increase of costs among those who received intervention. We observed that LOS was shortened for patients with PCI and for patients with CABG (albeit slowly) during the study period; however, the increased costs per unit of intervention might have outweighed the effect of shortened LOS on total costs per hospitalization.

At the national level, aggregate national hospital costs for AMI hospitalizations decreased by 9% during the study period (these figures did not include physician fees). The drastically decreased incidence of AMI hospitalizations was mostly offset by the increased hospital costs per hospitalization, especially for AMI with intervention. Curbing the increasing hospital costs per hospitalization may be critical to reduce total health expenditure spent on the treatment of AMI in the United States.

Our study has several limitations. First, as with any studies using administrative data, errors in recording diagnoses are possible. However, HCUP data are shown to be relatively accurate, and widely used to estimate diagnoses, procedures, and healthcare expenditures.^[@b28]--[@b29]^ Second, due to advances in technology related to PCI, severe AMI cases who would have been treated with CABG a decade ago, are more likely to be treated by PCI in recent years. This does not affect a consistent improvement across the treatment type among NSTEMI patients, but it may explain non‐significant improvement in mortality among the STEMI patients who underwent CABG. Third, the HCUP NIS contains discharge‐level records, not patient‐level records, and thus we were unable to identify multiple hospitalizations for each patient. Fourth, the lack of patient identifiers in the NIS precluded us from using other mortality measures such as 30‐day mortality. Previous studies using data from MIDAS in New Jersey found that in‐hospital declines in mortality were observed but the post‐discharge AMI mortality in fact increased.^[@b30]^ Our findings cannot be extrapolated to the other outcome measures of the AMI patients, but we believe that the national estimates of the in‐hospital mortality over time are valuable information for clinicians and policy makers. Fifth, although we adjusted for both patient‐ and hospital‐level characteristics in evaluating the change in in‐hospital mortality and hospital costs, there may be unmeasured time‐varying confounders. Sixth, the HCUP charges do not include physician fees, thereby leading to underestimation of total costs per AMI hospitalization. However, it is unlikely the proportion of physician fees out of total costs has increased over time differently across the type of AMI and the intervention received; therefore, this may not confound our findings. Lastly, due to the nature of HCUP NIS dataset, costs of care after discharges were unknown. Likosky and colleagues showed more rapid increase in expenditures occurring after discharge using data of fee‐for‐service Medicare beneficiaries.^[@b31]^ Additional data and analyses are needed to obtain broader understanding about financial burden of AMI incidence.

This study has several important implications. Because AMI continues to be one of the major public health burdens in our healthcare system, the rising spending for AMI hospitalizations should encourage policy makers and health services researchers to develop more cost‐effective approaches for the management of AMI. Identification and development of strategies for reducing the costs of AMI hospitalizations accompanied by interventions (ie, PCI and/or CABG) may be an effective approach to reducing the net financial burden of AMI on healthcare systems. For clinicians, the observed decline in the mortality in patients with NSTEMI is encouraging and supports the prior optimism that AMI morbidity and mortality can be prevented.

Conclusions
===========

In summary, using a large nationally representative database of US hospitalizations in 2001--2011, we found that in‐hospital mortality decreased significantly for NSTEMI regardless of the type of treatment they received. By contrast, we found significant improvement only for STEMI with PCI; no significant improvement was observed for STEMI patients who received CABG and those without intervention. Hospital costs increased significantly for those who received intervention, and the rate of increase in hospital costs was most prominent among those patients who underwent CABG. These non‐uniform temporal trends may be informative for designing effective health policies that reduce the health and economic burdens of AMI in the United States.
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